{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:14:29Z","timestamp":1772165669163,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Norovirus is now recognized to be major cause of gastroenteritis worldwide, with significantly higher disease burden among immunocompromised patients. This study aimed to determine the prevalence of Norovirus among HIV-infected patients and to evaluate the impact of combination antiretroviral therapy (cART) status on Norovirus prevalence in a sub-urban area of Abuja, Nigeria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study included a total of Two hundred and fifteen subjects (85 cART-na\u00efve and 130 cART-exposed) HIV-infected patients. Age range of study participants was 18 to 60 years. Faecal specimens where collected in screw capped containers and analyzed for Norovirus using Accupower Norovirus real-time PCR Test kit. CD4\u2009+\u2009cell count was determined using flow cytometry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The prevalence of Norovirus among cART-na\u00efve HIV-infected patients was 10.6%. Age and gender was not associated with norovirus infection. cART \u2013na\u00efve HIV-infected patients with CD4\u2009+\u2009cell count\u2009&lt;\u2009200 was significantly more infected with Norovirus as compared to those with CD4\u2009+\u2009count\u2009\u2265\u2009200 (OR: 28.000, 95% CI 3.2237, 243.2007, P\u2009=\u20090.0025). Norovirus was also found to be significantly higher in cART-na\u00efve HIV-infected patients than amongst cART-exposed counterparts (OR: 6.882, 95% CI: 1.4514, 32.6343, P\u2009=\u20090.015).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The prevalence of Norovirus among cART-na\u00efve HIV-infected patients was high; and was significantly higher in subjects with low CD4\u2009+\u2009counts. Screening for Norovirus among cART-na\u00efve HIV-infected patients is however emphasized to allow for effective Norovirus disease management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-023-08592-3","type":"journal-article","created":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T10:03:51Z","timestamp":1695290631000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Norovirus infection among HIV-infected patients in Abuja, Nigeria: impact of combination antiretroviral therapy status"],"prefix":"10.1186","volume":"23","author":[{"given":"Favour","family":"Osazuwa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William Olayemi","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hailey Seth","family":"Grobler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,21]]},"reference":[{"issue":"1","key":"8592_CR1","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1146\/annurev-food-022814-015643","volume":"6","author":"MD Moore","year":"2015","unstructured":"Moore MD, Goulter RM, Jaykus L. Human norovirus as a Foodborne Pathogen: Challenges and Developments. Ann Rev Food Sci Tech. 2015;6(1):411\u201333.","journal-title":"Ann Rev Food Sci Tech"},{"issue":"10","key":"8592_CR2","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1056\/NEJMc1301022","volume":"368","author":"K Bok","year":"2013","unstructured":"Bok K, Gren KY. Norovirus Gastroenteritis in Immunocompromised Patients. New Engl J Med. 2013;368(10):971.","journal-title":"New Engl J Med"},{"issue":"8","key":"8592_CR3","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/1469-0691.12761","volume":"20","author":"KY Green","year":"2014","unstructured":"Green KY. Norovirus infection in immunocompromised hosts. Clin Micro Infect. 2014;20(8):717\u201323.","journal-title":"Clin Micro Infect"},{"issue":"1","key":"8592_CR4","doi-asserted-by":"publisher","first-page":"e236913","DOI":"10.1136\/bcr-2020-236913","volume":"14","author":"G Ashton","year":"2021","unstructured":"Ashton G, Shand A, Arnott I, Din S. Profound diarrhea and weight loss in an immunocompromised patient. BMJ Case Rep. 2021;14(1):e236913.","journal-title":"BMJ Case Rep"},{"issue":"40","key":"8592_CR5","doi-asserted-by":"publisher","first-page":"e8139","DOI":"10.1097\/MD.0000000000008139","volume":"96","author":"GT Nguyen","year":"2017","unstructured":"Nguyen GT, Phan K, Teng I, Pu J, Watanabe T. A systematic review and meta-analysis of the prevalence of norovirus in cases of gastroenteritis in developing countries. Medicine. 2017;96(40):e8139.","journal-title":"Medicine"},{"issue":"5","key":"8592_CR6","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s11894-006-0026-4","volume":"8","author":"R Goodgame","year":"2006","unstructured":"Goodgame R. Norovirus gastroenteritis. Curr Gastroenterol Rep. 2006;8(5):401\u20138.","journal-title":"Curr Gastroenterol Rep"},{"issue":"6","key":"8592_CR7","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1177\/0956462418824912","volume":"30","author":"S Yang","year":"2019","unstructured":"Yang S, Li M, Cheng J, et al. Diagnostic determination of Norovirus infection as one of the major causes of infectious diarrhea in HIV patients using a multiplex polymerase chain reaction assay. Int J STD & AIDS. 2019;30(6):550\u20136.","journal-title":"Int J STD & AIDS"},{"issue":"6","key":"8592_CR8","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/rmv.704","volume":"21","author":"GE Rydell","year":"2011","unstructured":"Rydell GE, Kindberg E, Larson G, Svensson L. Susceptibility to winter vomiting disease: a sweet matter. Rev Med Virol. 2011;21(6):370\u201382.","journal-title":"Rev Med Virol"},{"issue":"Suppl 1","key":"8592_CR9","first-page":"71","volume":"19","author":"M Meidani","year":"2014","unstructured":"Meidani M, Naeini AE, Rostami M, Sherkat R, Tayeri K. Immunocompromised patients: review of the most common infections happened in 446 hospitalized patients. J Res Med Sci. 2014;19(Suppl 1):71\u20133.","journal-title":"J Res Med Sci"},{"issue":"4","key":"8592_CR10","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.jaci.2007.08.053","volume":"120","author":"RS Geha","year":"2007","unstructured":"Geha RS, Notarangelo LD, Casanova JL, Chapel H, Conley ME, Fischer A, Hammarstr\u00f6m L, Nonoyama S, Ochs HD, Puck JM, Roifman C, Seger R, Wedgwood J, International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases classification Committee. J Allergy Clin Immunol. 2007;120(4):776\u201394.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"8592_CR11","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jcv.2010.07.025","volume":"49","author":"T Wingfield","year":"2010","unstructured":"Wingfield T, Gallimore CI, Xerry J, Gray JJ, Klapper P, Guiver M, Blanchard TJ. Chronic norovirus infection in an HIV-positive patient with persistent diarrhea: a novel cause. J Clin Virol. 2010;49(3):219\u201322.","journal-title":"J Clin Virol"},{"issue":"7","key":"8592_CR12","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1086\/605558","volume":"49","author":"LK Hoonmo","year":"2009","unstructured":"Hoonmo LK, Herbert LD. Noroviruses as a potential cause of protracted and Lethal Disease in Immunocompromised Patients. Clin Infect Dis. 2009;49(7):1069\u201371.","journal-title":"Clin Infect Dis"},{"key":"8592_CR13","doi-asserted-by":"crossref","unstructured":"Oude Munnink BB, Canuti M, Deijs M et al. Unexplained diarrhoea in HIV-1 infected individuals. BMC Infect Dis. 2014; 14 (22).","DOI":"10.1186\/1471-2334-14-22"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08592-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-023-08592-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08592-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T22:06:59Z","timestamp":1700604419000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-023-08592-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,21]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["8592"],"URL":"https:\/\/doi.org\/10.1186\/s12879-023-08592-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3142055\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,21]]},"assertion":[{"value":"5 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All components of this study were approved by the Local Health authority of Abaji Local Government area (HEC\/LHA:130A5). All procedures were performed in accordance with the ethical guidelines and regulations. Informed consent was obtained from all participants\/legal guardians.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declaration"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Foot notes"}}],"article-number":"623"}}